CAD 0.42
(-1.19%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | -6.51 Million | -7.23 Million | -5.51 Million | -556.75 Thousand | -609.24 Thousand | 83.19 Thousand |
Net Income | -5.34 Million | -6.66 Million | -5.22 Million | -1.19 Million | -302.41 Thousand | -429.76 Thousand |
Depreciation & Amortization | 10.67 Thousand | 62.52 Thousand | 62.51 Thousand | -711.1 Thousand | 4387.00 | - |
Deferred income taxes | - | - | - | -40.61 Thousand | -4387.00 | - |
Stock-based compensation | 815.93 Thousand | 776.01 Thousand | 354.88 Thousand | 729.67 Thousand | 67.11 Thousand | 228.16 Thousand |
Change in working capital | 484.9 Thousand | 63.01 Thousand | -201.2 Thousand | -53.02 Thousand | -369.55 Thousand | 284.78 Thousand |
Other non-cash items | -2.47 Million | -1.46 Million | -508.56 Thousand | 711.1 Thousand | -4387.00 | -70.71 Thousand |
Investing Cash Flow | - | 108.17 Thousand | -391.73 Thousand | - | - | 50 Thousand |
Investments in PPE | - | - | -146.39 Thousand | - | - | - |
Acquisitions | - | - | - | - | - | 50 Thousand |
Investment purchases | - | - | -108.17 Thousand | - | - | - |
Sales/Maturities of investments | - | 108.17 Thousand | - | - | - | - |
Other Investing Activities | - | - | -137.17 Thousand | - | - | - |
Financing Cash Flow | 8.16 Million | 7.21 Million | 8.76 Million | 3.12 Million | 181.4 Thousand | 146 Thousand |
Debt repayment | - | - | - | - | - | - |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | 8.42 Million | 7 Million | 9.02 Million | 3.03 Million | 112.65 Thousand | 146 Thousand |
Other Financing Activities | -332.72 Thousand | 214.19 Thousand | -258.55 Thousand | 85 Thousand | 68.75 Thousand | - |
Accounts receivables | - | -41.24 Thousand | - | -22.04 Thousand | 60.1 Thousand | -8758.00 |
Accounts payables | - | - | 221.95 Thousand | 45.67 Thousand | -349.16 Thousand | 307.64 Thousand |
Inventory | - | - | - | - | - | - |
Other working capital | -13 Thousand | 104.25 Thousand | -423.15 Thousand | -76.65 Thousand | -80.5 Thousand | -14.09 Thousand |
Cash at beginning of period | 5.88 Million | 5.79 Million | 2.94 Million | 378.88 Thousand | 806.72 Thousand | 527.53 Thousand |
Cash at end of period | 7.54 Million | 5.88 Million | 5.79 Million | 2.94 Million | 378.88 Thousand | 806.72 Thousand |
Capital Expenditure | - | - | -146.39 Thousand | - | - | - |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | 1.65 Million | 92.26 Thousand | 2.85 Million | 2.56 Million | -427.84 Thousand | 279.19 Thousand |
Free Cash Flow | -6.51 Million | -7.23 Million | -5.66 Million | -556.75 Thousand | -609.24 Thousand | 83.19 Thousand |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | -2.19 Million | -1.1 Million | -1.85 Million | -5.34 Million | -1.6 Million | -1.08 Million |
Depreciation & Amortization | 10.82 Thousand | 2670.00 | 2670.00 | 10.67 Thousand | 2669.00 | 2670.00 |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | 226.94 Thousand | 187.17 Thousand | 341.76 Thousand | 815.93 Thousand | 153.71 Thousand | 165.85 Thousand |
Change in working capital | -194.61 Thousand | -345.66 Thousand | -154.82 Thousand | 484.9 Thousand | 351.54 Thousand | 178.46 Thousand |
Other non-cash items | 134.91 Thousand | 162.97 Thousand | -871.15 Thousand | -2.47 Million | -928.56 Thousand | -450.72 Thousand |
Investing Cash Flow | -6594.00 | - | - | - | - | - |
Investments in PPE | -1.00 | - | - | - | - | - |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | -6594.00 | - | - | - | - | - |
Financing Cash Flow | 478.91 Thousand | 1.4 Million | 6.09 Million | 8.16 Million | - | - |
Debt repayment | - | - | - | - | - | - |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | 478.91 Thousand | 1.4 Million | 6.42 Million | 8.42 Million | - | - |
Other Financing Activities | 478.91 Thousand | - | -298.55 Thousand | -332.72 Thousand | - | - |
Accounts receivables | -29.08 Thousand | -21.09 Thousand | - | - | 63.8 Thousand | -82.2 Thousand |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | -165.53 Thousand | -324.56 Thousand | 5750.00 | -13 Thousand | 287.73 Thousand | 260.66 Thousand |
Cash at beginning of period | 7.63 Million | 7.54 Million | 3.97 Million | 5.88 Million | 6 Million | 7.19 Million |
Cash at end of period | 5.81 Million | 7.63 Million | 7.54 Million | 7.54 Million | 3.97 Million | 6 Million |
Capital Expenditure | -1.00 | - | - | - | - | - |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | -1.82 Million | 95.14 Thousand | 3.56 Million | 1.65 Million | -2.02 Million | -1.18 Million |
Free Cash Flow | -2.29 Million | -1.3 Million | -2.53 Million | -6.51 Million | -2.02 Million | -1.18 Million |
FGR
0HF7
JOY
INDP
VALIANTLAB
DEF